04 June 2024
04 June 2024
Article doesn't exist
Keeping high-qualified, experienced clinical trial staff on board plays a crucial role in bringing new drugs to market.
From 3 June, ASCO’s cancer.net domain will be retired, and the organisations’ combined information repository will be available at Cancer.org.
At the ASCO annual meeting, Tagrisso showed an improvement in progression free survival compared to placebo.
GSK says it disagrees with the ruling by the Delaware State Court and will immediately seek an appeal.
The committee’s positive opinion is based on results from the Phase III FLAURA2 clinical trial.
QRL-204 is designed to restore UNC13A function, a gene identified as a risk factor in neurodegenerative diseases, including ALS and dementia.
EryDex is being evaluated in the Phase III NEAT study, which will enrol over 100 patients with rare disease ataxia-telangiectasia.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
